Genes expressed in prostate cancer

The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in prostate cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the progression or treatment of prostate cancer.

Saved in:
Bibliographic Details
Main Authors Faris, Mary, Pearson, Cecelia
Format Patent
LanguageEnglish
Published 09.10.2003
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in prostate cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the progression or treatment of prostate cancer.